Dianthus Therapeutics | MGTA - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 411.27B 998.23M 2026-03
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
IQVIA Holdings USD 13.7B 284M 2026-06
Kangmei Pharma CNY 67.35M 1.22M 2026-06
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 597M 6M 2026-06
Organigram Holdings CAD 60.76M 1.77M 2026-03
Organon & Co USD 8.48B 74M 2026-06
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 32.13M 1.04M 2026-06
Qiagen NV USD 1.63B 19.45M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 17K 26K 2026-03
Tilray USD 268.59M 3.82M 2025-09
Viatris USD 11.61B 801.1M 2026-06
Xeris Pharmaceuticals USD 188.81M 32.42M 2026-06
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 172.8M 9.49M 2026-06